Sankala Group’s Pfizer PFE Stock Holding History

Sankala Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$981	Hold	36	–	–	﹤0.01%	526
2025 Q4	$990	Buy	+36	New	+$908	﹤0.01%	541

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sankala Group's PFE Position: Q1 2026 in Review

Sankala Group held its Pfizer (PFE) position steady in Q1 2026 at 36 shares worth $981. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Sankala Group first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. The position peaked at $990 in Q4 2025. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Sankala Group held 36 shares of Pfizer worth $981 as of Q1 2026.
Sankala Group left its Pfizer share count unchanged in Q1 2026.
Pfizer made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #526 holding.
Sankala Group first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
Sankala Group's Pfizer position peaked at $990 in Q4 2025.
2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.